{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:45:32Z","timestamp":1783647932170,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ontario cancer research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12022-023-09748-2","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T09:02:33Z","timestamp":1674723753000},"page":"257-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["FLCN-Driven Functional Adrenal Cortical Carcinoma with High Mitotic Tumor Grade: Extending the Endocrine Manifestations of Birt-Hogg-Dub\u00e9 Syndrome"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9977-6807","authenticated-orcid":false,"given":"Renee","family":"Hofstedter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7946-2026","authenticated-orcid":false,"given":"Mar\u00eda Carolina","family":"Sanabria-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Di Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8343-3068","authenticated-orcid":false,"given":"Shereen","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-2801","authenticated-orcid":false,"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2147-8674","authenticated-orcid":false,"given":"Raymond H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"issue":"8","key":"9748_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.14740\/jocmr3503w","volume":"10","author":"E Sharma","year":"2018","unstructured":"Sharma E, Dahal S, Sharma P, Bhandari A, Gupta V, Amgai B, Dahal S. The Characteristics and Trends in Adrenocortical Carcinoma: A United States Population Based Study. Journal of clinical medicine research. 2018;10(8):636-640.","journal-title":"Journal of clinical medicine research."},{"issue":"2","key":"9748_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/er.2013-1029","volume":"35","author":"T Else","year":"2014","unstructured":"Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD. Adrenocortical Carcinoma. Endocrine Reviews. 2014;35(2):282-326.","journal-title":"Endocrine Reviews."},{"issue":"3","key":"9748_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.mpdhp.2016.02.002","volume":"22","author":"B Gallinger","year":"2016","unstructured":"Gallinger B, Druker H, Gill AJ, Wasserman JD, Kim RH. The adrenal gland: an evolution of the roles of genetic counsellors and medical geneticists in endocrine cancers. Diagnostic Histopathology. 2016;22(3):108-122.","journal-title":"Diagnostic Histopathology."},{"key":"9748_CR4","doi-asserted-by":"crossref","unstructured":"Kim D, Murvelashvili N, Hamidi O, Jia L. Adrenal Cortical Carcinoma and Additional Rare Pathologic Findings in Multi-Organs in a Birt-Hogg-Dub\u00e9 Syndrome Patient: With an Emphasis on the Molecular Characteristics of Adrenal Cortical Carcinoma. International journal of surgical pathology. 2022:10668969221117246.","DOI":"10.1177\/10668969221117246"},{"issue":"1","key":"9748_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mce.2011.12.008","volume":"351","author":"T Else","year":"2012","unstructured":"Else T. Association of adrenocortical carcinoma with familial cancer susceptibility syndromes. Molecular and cellular endocrinology. 2012;351(1):66-70.","journal-title":"Molecular and cellular endocrinology."},{"issue":"5","key":"9748_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/EJE-17-0358","volume":"177","author":"T Else","year":"2017","unstructured":"Else T, Lerario AM, Everett J, Haymon L, Wham D, Mullane M, Wilson TL, Rainville I, Rana H, Worth AJ, Snyder NW, Blair IA, McKay R, Kilbridge K, Hammer G, et al. Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series. Eur J Endocrinol. 2017;177(5):439-444.","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"9748_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12022-021-09667-0","volume":"32","author":"CC Juhlin","year":"2021","unstructured":"Juhlin CC, Bertherat J, Giordano TJ, Hammer GD, Sasano H, Mete O. What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics. Endocr Pathol. 2021;32(1):102-133.","journal-title":"Endocr Pathol."},{"issue":"1","key":"9748_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M, Papotti MG. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors. Endocr Pathol. 2022;33(1):155-196.","journal-title":"Endocr Pathol."},{"issue":"1","key":"9748_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1210\/js.2018-00343","volume":"3","author":"C Xie","year":"2019","unstructured":"Xie C, Tanakchi S, Raygada M, Davis JL, Del Rivero J. Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation. J Endocr Soc. 2019;3(1):284-290.","journal-title":"J Endocr Soc."},{"issue":"36","key":"9748_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004756","volume":"95","author":"N El Ghorayeb","year":"2016","unstructured":"El Ghorayeb N, Grunenwald S, Nolet S, Primeau V, C\u00f4t\u00e9 S, Maugard CM, Lacroix A, Gaboury L, Bourdeau I. First case report of an adrenocortical carcinoma caused by a BRCA2 mutation. Medicine (Baltimore). 2016;95(36):e4756.","journal-title":"Medicine (Baltimore)."},{"key":"9748_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cancergen.2021.03.003","volume":"256\u2013257","author":"MB Torres","year":"2021","unstructured":"Torres MB, Diggs LP, Wei JS, Khan J, Miettinen M, Fasaye GA, Gillespie A, Widemann BC, Kaplan RN, Davis JL, Hernandez JM, Rivero JD. Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma. Cancer Genet. 2021;256-257:21-25.","journal-title":"Cancer Genet."},{"issue":"6","key":"9748_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1530\/EJE-20-1423","volume":"184","author":"LS Landwehr","year":"2021","unstructured":"Landwehr LS, Schreiner J, Appenzeller S, Kircher S, Herterich S, Sbiera S, Fassnacht M, Kroiss M, Weigand I. A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden. Eur J Endocrinol. 2021;184(6):823-835.","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"9748_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.2953","volume":"46","author":"G Assi\u00e9","year":"2014","unstructured":"Assi\u00e9 G, Letouz\u00e9 E, Fassnacht M, Jouinot A, Luscap W, Barreau O, Omeiri H, Rodriguez S, Perlemoine K, Ren\u00e9-Corail F, Elarouci N, Sbiera S, Kroiss M, Allolio B, Waldmann J, et al. Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics. 2014;46(6):607-612.","journal-title":"Nature Genetics."},{"issue":"5","key":"9748_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","volume":"29","author":"S Zheng","year":"2016","unstructured":"Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016;29(5):723-736.","journal-title":"Cancer Cell."},{"key":"9748_CR15","doi-asserted-by":"crossref","unstructured":"Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML, Ma W, Linehan WM, Zbar B, Schmidt LS. Expression of Birt-Hogg-Dub\u00e9 gene mRNA in normal and neoplastic human tissues. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2004;17(8):998\u20131011.","DOI":"10.1038\/modpathol.3800152"},{"key":"9748_CR16","unstructured":"Reese E, Sluzevich J, Kluijt I, Teertstra HJ, De Jong D, Horenblas S, Ryu J, Birt-Hogg-Dub\u00e9 Syndrome, in Cancer Syndromes, D.L. Riegert-Johnson, L.A. Boardman, and T. Hefferon, Editors. 2009, National Center for Biotechnology Information (US): Bethesda (MD)."},{"key":"9748_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.18632\/oncotarget.28176","volume":"13","author":"MR Woodford","year":"2022","unstructured":"Woodford MR, Andreou A, Baba M, van de Beek I, Di Malta C, Glykofridis I, Grimes H, Henske EP, Iliopoulos O, Kurihara M, Lazor R, Linehan WM, Matsumoto K, Marciniak SJ, Namba Y, et al. Seventh BHD international symposium: recent scientific and clinical advancement. Oncotarget. 2022;13:173-181.","journal-title":"Oncotarget."},{"issue":"1","key":"9748_CR18","first-page":"49","volume":"25","author":"E Kalloniati","year":"2021","unstructured":"Kalloniati E, Antoniades E, Athanasouli F. Birt-Hogg-Dub\u00e9 Syndrome and coexistence with adrenocortical carcinoma. Hippokratia. 2021;25(1):49-49.","journal-title":"Hippokratia."},{"key":"9748_CR19","doi-asserted-by":"crossref","unstructured":"Ramsingh J,Watson C. Oncocytoma of the adrenal gland in Birt-Hogg-Dube syndrome. BMJ case reports. 2018;2018.","DOI":"10.1136\/bcr-2018-224283"},{"issue":"6","key":"9748_CR20","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/cen.12292","volume":"80","author":"VM Raymond","year":"2014","unstructured":"Raymond VM, Long JM, Everett JN, Caoili EM, Gruber SB, Stoffel EM, Giordano TJ, Hammer GD, Else T. An oncocytic adrenal tumour in a patient with Birt-Hogg-Dub\u00e9 syndrome. Clinical endocrinology. 2014;80(6):925-7.","journal-title":"Clinical endocrinology."},{"key":"9748_CR21","doi-asserted-by":"crossref","unstructured":"Kunogi M, Kurihara M, Ikegami TS, Kobayashi T, Shindo N, Kumasaka T, Gunji Y, Kikkawa M, Iwakami S-i, Hino O, Takahashi K, Seyama K. Clinical and genetic spectrum of Birt-Hogg-Dube syndrome patients in whom pneumothorax and\/or multiple lung cysts are the presenting feature. Journal of medical genetics. 2010;47(4):281\u20137.","DOI":"10.1136\/jmg.2009.070565"},{"key":"9748_CR22","unstructured":"Juszczak A, Halliday D, Mihai R, Ali A. A large adrenal tumour as a phenotypic manifestation of the Birt-Hogg-Dube syndrome. in Endocrine Abstracts. 2011."},{"issue":"1","key":"9748_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.trecan.2019.11.006","volume":"6","author":"D Mandelker","year":"2020","unstructured":"Mandelker D,Ceyhan-Birsoy O. Evolving Significance of Tumor-Normal Sequencing in Cancer Care. Trends in Cancer. 2020;6(1):31-39.","journal-title":"Trends in Cancer."},{"issue":"5","key":"9748_CR24","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.3747\/co.26.5235","volume":"26","author":"ER Malone","year":"2019","unstructured":"Malone ER, Saleh RR, Yu C, Ahmed L, Pugh T, Torchia J, Bartlett J, Virtanen C, Hotte SJ, Hilton J, Welch S, Robinson A, McCready E, Lo B, Sadikovic B, et al. OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharing. Curr Oncol. 2019;26(5):e618-e623.","journal-title":"Curr Oncol."},{"issue":"2","key":"9748_CR25","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1530\/JME-18-0122","volume":"62","author":"JFH Pittaway","year":"2019","unstructured":"Pittaway JFH,Guasti L. Pathobiology and genetics of adrenocortical carcinoma. J Mol Endocrinol. 2019;62(2):R105-R119.","journal-title":"J Mol Endocrinol."},{"key":"9748_CR26","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1038\/ncomms7302","volume":"6","author":"EM Pinto","year":"2015","unstructured":"Pinto EM, Chen X, Easton J, Finkelstein D, Liu Z, Pounds S, Rodriguez-Galindo C, Lund TC, Mardis ER, Wilson RK, Boggs K, Yergeau D, Cheng J, Mulder HL, Manne J, et al. Genomic landscape of paediatric adrenocortical tumours. Nat Commun. 2015;6:6302.","journal-title":"Nat Commun."},{"issue":"2","key":"9748_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/PAS.0000000000000943","volume":"42","author":"O Mete","year":"2018","unstructured":"Mete O, Gucer H, Kefeli M, Asa SL. Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma. Am J Surg Pathol. 2018;42(2):201-213.","journal-title":"Am J Surg Pathol."},{"key":"9748_CR28","doi-asserted-by":"crossref","unstructured":"Brondani VB, Lacombe AMF, Mariani BMP, Montenegro L, Soares IC, Bezerra-Neto JE, Tanno FY, Srougi V, Chambo JL, Mendonca BB, Almeida MQ, Zerbini MCN, Fragoso MCBV. Low Protein Expression of both\u00a0ATRX\u00a0and\u00a0ZNRF3\u00a0as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma. Int J Mol Sci. 2021;22(3).","DOI":"10.3390\/ijms22031238"},{"key":"9748_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.667311","volume":"9","author":"JMJ Ramirez Reyes","year":"2021","unstructured":"Ramirez Reyes JMJ, Cuesta R, Pause A. Folliculin: A Regulator of Transcription Through AMPK and mTOR Signaling Pathways. Front Cell Dev Biol. 2021;9:667311.","journal-title":"Front Cell Dev Biol."},{"issue":"9","key":"9748_CR30","doi-asserted-by":"publisher","first-page":"R144","DOI":"10.1530\/EC-19-0224","volume":"8","author":"MC De Martino","year":"2019","unstructured":"De Martino MC, Feelders RA, Pivonello C, Simeoli C, Papa F, Colao A, Pivonello R, Hofland LJ. The role of mTOR pathway as target for treatment in adrenocortical cancer. Endocr Connect. 2019;8(9):R144-R156.","journal-title":"Endocr Connect."},{"issue":"10","key":"9748_CR31","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1158\/0008-5472.CAN-12-3876","volume":"73","author":"J Liang","year":"2013","unstructured":"Liang J,Mills GB. AMPK: a contextual oncogene or tumor suppressor? Cancer Res. 2013;73(10):2929-35.","journal-title":"Cancer Res."},{"issue":"31","key":"9748_CR32","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1038\/onc.2017.54","volume":"36","author":"M Batisse-Lignier","year":"2017","unstructured":"Batisse-Lignier M, Sahut-Barnola I, Tissier F, Dumontet T, Mathieu M, Drelon C, Pointud JC, Damon-Soubeyrand C, Marceau G, Kemeny JL, Bertherat J, Tauveron I, Val P, Martinez A, Lefran\u00e7ois-Martinez AM. P53\/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model. Oncogene. 2017;36(31):4445-4456.","journal-title":"Oncogene."},{"issue":"3","key":"9748_CR33","doi-asserted-by":"publisher","first-page":"E493","DOI":"10.1210\/jc.2014-3282","volume":"100","author":"CC Juhlin","year":"2015","unstructured":"Juhlin CC, Goh G, Healy JM, Fonseca AL, Scholl UI, Stenman A, Kunstman JW, Brown TC, Overton JD, Mane SM, Nelson-Williams C, B\u00e4ckdahl M, Suttorp AC, Haase M, Choi M, et al. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma. J Clin Endocrinol Metab. 2015;100(3):E493-502.","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-023-09748-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-023-09748-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-023-09748-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T08:22:00Z","timestamp":1686644520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-023-09748-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["9748"],"URL":"https:\/\/doi.org\/10.1007\/s12022-023-09748-2","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]},"assertion":[{"value":"9 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the OCTANE study was obtained by the Ontario Cancer Research Ethics Board, OCREB (CAPCR 16-5655; Submitted 2016\/06\/10).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from the patient to be enrolled in the OCTANE study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Informed consent was obtained from the patient for the publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Dr. Ozgur Mete is the Editor-in-Chief of\u00a0<i>Endocrine Pathology<\/i>. This article was handled by an independent senior editor. The other authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}